<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-IND-T-FIND</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Strengthening health systems for sustainable access to quality diagnosis, engagement of private sector, management of latent TB and amplifying community action for achieving TB elimination in India</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">India - Tuberculosis - Foundation for Innovative New Diagnostics India - FIND.  This program has the following goals: To achieve a rapid decline in burden of TB, morbidity and mortality to achieve the Sustainable Development Goals of 80% reduction in incidence and 90% reduction in deaths by 2025; five years earlier than the stipulated timeline.. The objectives of this program are: Build, strengthen and sustain enabling policies, empowered institutions, multi-sectoral collaborations, engaged communities, and human resources with enhanced capacities to create a supportive ecosystem to END TB..  Prevent the emergence of TB in susceptible populations.</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM India</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="639953eb-32c1-4c94-a08e-9d61b0e77d93" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="IND-T-FIND" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-09-27" type="1"></activity-date>
  <activity-date iso-date="2017-09-27" type="2"></activity-date>
  <activity-date iso-date="2024-03-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Richard CUNLIFFE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>richard.cunliffe@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.26" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="6.5" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="26.96" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="27.09" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="0.66" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="18.03" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="3.06" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="3.66" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="1.78" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="0.73" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="0.56" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="1.24" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="9.48" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">581767</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-04-01"></period-start>
   <period-end iso-date="2018-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">581767</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-07-01"></period-start>
   <period-end iso-date="2018-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">581767</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-10-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">2870134</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1478646</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">1893037</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">2466963</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1560155</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">1795273</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2018-01-01">3404106</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2018-01-01">2457852</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2018-01-01">12290259</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2018-01-01">16842009</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">1931744</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">2257159</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">2888340</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">3762955</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">4017887</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">3691331</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">3035822</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">3723677</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-04-01">3854924</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-04-01">3368951</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-04-01">2842139</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="USD" value-date="2021-04-01">2284428</value>
  </budget>
  <capital-spend percentage="26.96"></capital-spend>
  <transaction ref="32ad41d2-aa1e-40f5-b1e9-e1b9de75815b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-15"></transaction-date>
   <value currency="USD" value-date="2018-02-15">16274982.26</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7ba2edc8-fa67-46b5-be9b-7815e3dc942e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-19"></transaction-date>
   <value currency="USD" value-date="2019-09-19">-5659699.94</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b44ecf9d-9fb9-492c-bf63-2440ff3be0a3">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-19"></transaction-date>
   <value currency="USD" value-date="2019-09-19">13779980.24</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b280a339-8dc8-444b-b049-7a11b2d3146e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-02"></transaction-date>
   <value currency="USD" value-date="2020-09-02">-5532286.24</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9beef2cd-8d90-4e00-9f10-814f6b5de8e5">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-02"></transaction-date>
   <value currency="USD" value-date="2020-09-02">8020361.62</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d64dbd7a-5b30-4902-90a7-232102c9bd1a">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-11-19"></transaction-date>
   <value currency="USD" value-date="2020-11-19">-6913120.62</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="833d2321-a6dd-43c0-abd1-a084c4f20ca2">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-11-19"></transaction-date>
   <value currency="USD" value-date="2020-11-19">28833504.68</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2c17c556-63e4-48cb-b4bb-fb103494e60f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-05-03"></transaction-date>
   <value currency="USD" value-date="2021-05-03">18549407.04</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2fbc8011-1303-4bf0-9974-09ae5e102b8f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-15"></transaction-date>
   <value currency="USD" value-date="2021-09-15">-14350483.68</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3dce4387-1653-4f06-8f74-465b16009d61">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-16"></transaction-date>
   <value currency="USD" value-date="2018-02-16">1042518.32</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ad5c533c-7e3b-4a01-a1d2-638e4bd7bca1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-07-31"></transaction-date>
   <value currency="USD" value-date="2018-07-31">4712470</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="22f62744-0894-4fc5-8a55-6a864110da46">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-02-07"></transaction-date>
   <value currency="USD" value-date="2019-02-07">4860294</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ec99f7d1-006f-449b-ac86-ae0be731f48b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">1825792</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4e785210-c505-4af0-8eef-bb7e9651f93c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-12"></transaction-date>
   <value currency="USD" value-date="2019-12-12">4704353</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0fe4d068-75a1-4acc-b4a6-edaac6afa091">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-03"></transaction-date>
   <value currency="USD" value-date="2020-04-03">1717549</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8310f3be-1a1c-459b-ad0a-b6cf28f7fcd0">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-09"></transaction-date>
   <value currency="USD" value-date="2020-09-09">1107241</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b8795d2c-dd47-4195-affb-5cd5444b2d6d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-25"></transaction-date>
   <value currency="USD" value-date="2020-11-25">3172214</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4d7cf294-b97f-4abf-874a-328dde560f3e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-23"></transaction-date>
   <value currency="USD" value-date="2021-04-23">11310807</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="795a5f6c-9dad-4e26-8839-cebc16bd3333">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-07"></transaction-date>
   <value currency="USD" value-date="2021-05-07">1931742</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b96b56c1-8afe-44a7-9138-6528ef6e1a6f">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-12"></transaction-date>
   <value currency="USD" value-date="2021-08-12">3124551</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to IND-T-FIND.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Foundation for Innovative New Diagnostics India</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for IND-T-FIND</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 1561328 Denominator: 1908683 Percentage: 81.80</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1134000 Denominator: 1350000 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1859804 Denominator: 2188005 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2012400 Denominator: 2340000 Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 127.2</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 159.34</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 209</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 131.08</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 179</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 197</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 36%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 58347 Denominator: 130000 Percentage: 44.88</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 58347 Denominator: 130000 Percentage: 44.88</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 66359 Denominator: 124000 Percentage: 53.52</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 59400 Denominator: 130000 Percentage: 45.69</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 71078 Denominator: 130000 Percentage: 54.68</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 82800 Denominator: 130000 Percentage: 63.69</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2013">
     <comment>
      <narrative xml:lang="EN">Text: 46%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 15934.56 Denominator: 33197 Percentage: 48.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 15872 Denominator: 33197 Percentage: 47.81</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 48511 Denominator: 74632 Percentage: 65.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 17699 Denominator: 36043 Percentage: 49.11</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15687 Denominator: 32682 Percentage: 48.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 60590 Denominator: 108196 Percentage: 56.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 59%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 1994000 Denominator: 2690000 Percentage: 74.13</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 1839184 Denominator: 2690000 Percentage: 68.37</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 2160000 Denominator: 2640000 Percentage: 81.82</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2400000 Denominator: 3131884 Percentage: 76.63</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2680000 Denominator: 3085600 Percentage: 86.86</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 2880000 Denominator: 3040000 Percentage: 94.74</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for IND-T-FIND</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 10214 Denominator: 14266 Percentage: 71.60</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; private/non-governmental facilities</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 20965</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TCP-Other 4: Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated from private/non-governmental facilities</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 257768 Denominator: 317361 Percentage: 81.22</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 36 Denominator: 81 Percentage: 44.44</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">MDR TB-Other 1: Percentage of CBNAAT laboratories (GeneXpert) showing adequate performance on External Quality Assurance</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 651 Denominator: 664 Percentage: 98.04</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for IND-T-FIND</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 199.3</narrative>
     </comment>
    </baseline>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 217</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 142</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 183</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 174</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 164</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 33.3</narrative>
     </comment>
    </baseline>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 32</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 32</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-10-01"></period-start>
     <period-end iso-date="2021-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 24</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 32</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-04-01"></period-start>
     <period-end iso-date="2021-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-10-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 27</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2022-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Text: 2.84%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-09-30"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 2.84</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-10-01"></period-start>
     <period-end iso-date="2020-03-31"></period-end>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 87 Denominator: 3065 Percentage: 2.84</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
